Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Adherium Ltd. ( (AU:ADR) ) is now available.
Adherium Limited announced significant progress in expanding its U.S. market presence through new agreements with AMC Health and Tenovi, which have started integrating and onboarding patients with Adherium’s Hailie® Smartinhaler™ solution. The company reported increased customer receipts and secured an R&D loan to support innovation. Adherium is exploring entry into the Pharmacy Benefit Management segment, projected to grow steadily, and is collaborating with Australian universities to advocate for its solutions. The company aims to onboard 9,000 active patients by the end of 2025, reflecting its growth strategy and potential impact on stakeholders.
More about Adherium Ltd.
Adherium Limited is a leading digital health company specializing in connected respiratory medical devices. It offers integrated digital health solutions and is known for its Hailie® Smartinhaler™ technology, aimed at improving respiratory care and expanding its reach within the healthcare market.
YTD Price Performance: 50.0%
Average Trading Volume: 347,188
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$11.38M
Find detailed analytics on ADR stock on TipRanks’ Stock Analysis page.
